Teva Chosen As 'Bellwether' In US Price-Fixing Litigation

Case Involving Israeli Generics Giant Selected As Priority For Trial

 
• By David Wallace
Gavel
The decision is the latest development in US price-fixing litigation • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin